
Recent research by scientists from Albert Einstein College of Medicine and Utrecht University sheds light on the activation of dormant breast cancer cells by respiratory viruses such as SARS-CoV-2 and influenza. The study highlights the potential risks and long-term impacts of viral infections on cancer remission. Insights reveal a correlation between COVID-19 and breast cancer recurrence, indicating how these viruses may trigger dormant cancer cells. The activation process and associated risks are explained in detail, emphasizing the importance of understanding and addressing these concerns for cancer survivors.